Skip to main content

Table 2 SNPs main features of circadian genes tested in this study

From: Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis

Gene

SNP ID

Genotype

Ctrls

Cases

P-val.

Chr

Region

Residue

Ref in cancer

CLOCK

rs1801260

TT

323

92

0.21

4

3′-UTR

 

[10, 12, 13, 15, 16, 25, 27, 33, 34]

  

TC

228

62

     
  

CC

56

8

     
 

rs3736544

GG

241

60

0.72

4

Exon

Asn>Asn

 
  

GA

269

78

     
  

AA

95

24

     
 

rs3749474

CC

259

62

0.45

4

3′-UTR

 

[10, 15, 16, 33, 35]

  

CT

266

80

     
  

TT

83

20

     
 

rs34897046

GG

566

149

0.60

4

Exon

Ser>Cys

 
  

GC

40

13

     
  

CC

1

0

     

NPAS2

rs895520

GG

211

49

0.20

2

Intron

 

[10, 26, 27, 36,37,38]

  

GA

294

76

     
  

AA

103

37

     
 

rs2305160

GG

283

75

1.00

2

Exon

Thr>Ala

[10, 14, 15, 21, 23, 26, 27, 34,35,36,37,38,39,40,41,42,43,44,45]

  

GA

264

71

     
  

AA

59

16

     

PER1

rs3027178

TT

281

84

0.29

17

Exon

Thr>Thr

[10, 17, 28, 46]

  

TG

253

64

     
  

GG

76

14

     

PER2

rs934945

CC

386

118

0.07

2

Exon

Gly>Glu

[10, 17, 24,25,26,27,28, 36, 37, 46]

  

CT

206

42

     
  

TT

17

2

     
 

rs7602358

TT

358

87

0.49

2

Intron

 

[10, 23, 27, 36,37,38, 40]

  

TG

213

64

     
  

GG

38

11

     

RORA

rs339972

TT

312

97

0.15

15

Intron

 

[10, 27, 36, 37]

  

TC

233

53

     
  

CC

62

12

     
 

rs10519097

CC

422

110

0.67

15

Intron

 

[10, 27, 36, 37]

  

CT

173

50

     
  

TT

14

2

     

TIMELESS

rs774027

AA

157

44

0.63

12

Exon

Ile > Val

[10, 23, 27, 38]

  

AT

301

74

     
  

TT

148

44

     
 

rs3809125

CC

250

70

0.87

12

Upstream

  
  

CT

280

71

     
  

TT

74

20

     
 

rs7302060

TT

181

55

0.53

12

Intron

 

[10, 20,21,22]

  

TC

304

74

     
  

CC

121

33

     
  1. Ctrl controls, P-val P value, Chr chromosome, Region Gene region, Residue residue change, Ref in cancer reference in the literature regarding cancer associations